Sirt1 inhibits resistin expression in aortic stenosis

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Carter, Sophie ^a   Miard, Stéphanie ^a   Roy Bellavance, Catherine ^a   Boivin, Louise ^a   Li, Zhuo ^a   Pibarot, Philippe ^a   Mathieu, Patrick ^a   Picard, Frédéric ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN C JUN; RESISTIN; RESVERATROL; SIRTUIN 1; TRANSCRIPTION FACTOR AP 1; LIPOPOLYSACCHARIDE; STILBENE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE;

ADULT; AGED; AORTA STENOSIS; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSIVE ELEMENT; DOWN REGULATION; GENE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE ACTIVATION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; RESISTIN GENE; SIRTUIN 1 GENE; TRANSACTIVATION; ANIMAL; AORTA VALVE; AORTA VALVE STENOSIS; BINDING SITE; BIOSYNTHESIS; CELL CULTURE; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MIDDLE AGED; MOUSE; PROTEIN BINDING;

AGED; ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; BINDING SITES; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MIDDLE AGED; PROTEIN BINDING; RESISTIN; RESPONSE ELEMENTS; RNA, MESSENGER; SIRTUIN 1; STILBENES; TRANSCRIPTION, GENETIC;

EID: 84859510235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035110     Document Type: Article

References (48)

1. Charest A, Pepin A, Shetty R, Cote C, Voisine P, et al. (2006) Distribution of SPARC During Neovascularization of Degenerative Aortic Stenosis. Heart 92: 1844-1849.
2. Hopkins RA, (2006) Bioprosthetic valves and laudable inflammation? Circulation 114: 261-264.
3. Mathieu P, Pibarot P, Despres JP, (2006) Metabolic syndrome: the danger signal in atherosclerosis. Vasc Health Risk Manag 2: 285-302.
4. Mathieu P, Voisine P, Pepin A, Shetty R, Savard N, et al. (2005) Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. J Heart Valve Dis 14: 353-357.
5. Lindroos M, Kupari M, Heikkila J, Tilvis R, (1993) Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. Journal of the American College of Cardiology 21: 1220-1225.
6. Helske S, Kupari M, Lindstedt KA, Kovanen PT, (2007) Aortic valve stenosis: an active atheroinflammatory process. Curr Opin Lipidol 18: 483-491.
7. Agmon Y, Khandheria BK, Meissner I, Sicks JR, O'Fallon WM, et al. (2001) Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 38: 827-834.
8. Nollert G, Miksch J, Kreuzer E, Reichart B, (2003) Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement. J Thorac Cardiovasc Surg 126: 965-968.
9. Derbali H, Bosse Y, Cote N, Pibarot P, Audet A, et al. (2010) Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2. The American journal of pathology 176: 2638-2645.
10. Bosse Y, Miqdad A, Fournier D, Pepin A, Pibarot P, et al. (2009) Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves. Circ Cardiovasc Genet 2: 489-498.
11. Yetkin E, Waltenberger J, (2009) Molecular and cellular mechanisms of aortic stenosis. Int J Cardiol 135: 4-13.
12. Mohty D, Pibarot P, Despres JP, Cartier A, Arsenault B, et al. (2010) Age-related differences in the pathogenesis of calcific aortic stenosis: the potential role of resistin. Int J Cardiol 142: 126-132.
13. Patel SD, Rajala MW, Rossetti L, Scherer PE, Shapiro L, (2004) Disulfide-dependent multimeric assembly of resistin family hormones. Science 304: 1154-1158.
14. Lee TS, Lin CY, Tsai JY, Wu YL, Su KH, et al. (2009) Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages. Life Sci 84: 97-104.
15. Xu W, Yu L, Zhou W, Luo M, (2006) Resistin increases lipid accumulation and CD36 expression in human macrophages. Biochem Biophys Res Commun 351: 376-382.
16. Rae C, Graham A, (2006) Human resistin promotes macrophage lipid accumulation. Diabetologia 49: 1112-1114.
17. Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, et al. (2006) Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 69: 76-85.
18. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, et al. (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111: 932-939.
19. Ohmori R, Momiyama Y, Kato R, Taniguchi H, Ogura M, et al. (2005) Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. Journal of the American College of Cardiology 46: 379-380.
20. Guarente L, (2011) Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. The New England journal of medicine 364: 2235-2244.
21. Guarente L, Picard F, (2005) Calorie restriction-the SIR2 connection. Cell 120: 473-482.
22. Stein S, Lohmann C, Schafer N, Hofmann J, Rohrer L, et al. (2010) SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. European heart journal 31: 2301-2309.
23. Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng W, et al. (2008) Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovascular research 80: 191-199.
24. Zhang R, Chen HZ, Liu JJ, Jia YY, Zhang ZQ, et al. (2010) SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem 285: 7097-7110.
25. Yoshizaki T, Schenk S, Imamura T, Babendure JL, Sonoda N, et al. (2010) SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 298: E419-E428.
26. Shen Z, Ajmo JM, Rogers CQ, Liang X, Le L, et al. (2009) Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. American journal of physiology Gastrointestinal and liver physiology 296: G1047-G1053.
27. Nakamaru Y, Vuppusetty C, Wada H, Milne JC, Ito M, et al. (2009) A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J 23: 2810-2819.
28. Shetty R, Pibarot P, Audet A, Janvier R, Dagenais F, et al. (2009) Lipid-mediated inflammation and degeneration of bioprosthetic heart valves. European journal of clinical investigation 39: 471-480.
29. Kang L, Heng W, Yuan A, Baolin L, Fang H, (2010) Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses. Biochimie 92: 789-796.
30. Mercader J, Palou A, Bonet ML, (2010) Resveratrol enhances fatty acid oxidation capacity and reduces resistin and Retinol-Binding Protein 4 expression in white adipocytes. The Journal of nutritional biochemistry 22: 828-834.
31. Cote C, Pibarot P, Despres JP, Mohty D, Cartier A, et al. (2008) Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis. Heart 94: 1175-1180.
32. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, et al. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429: 771-776.
33. Picard F, Géhin M, Annicotte J-S, Rocchi S, Champy MF, et al. (2002) SRC-1 and TIF2 control energy fluxes between white and brown adipose tissues. Cell 111: 931-941.
34. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL, (2002) Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Letters 530: 158-162.
35. Shyu KG, Chua SK, Wang BW, Kuan P, (2009) Mechanism of inhibitory effect of atorvastatin on resistin expression induced by tumor necrosis factor-alpha in macrophages. Journal of biomedical science 16: 50.
36. Hess J, Angel P, Schorpp-Kistner M, (2004) AP-1 subunits: quarrel and harmony among siblings. Journal of cell science 117: 5965-5973.
37. Gao Z, Ye J, (2008) Inhibition of transcriptional activity of c-JUN by SIRT1. Biochemical and Biophysical Research Communications 376: 793-796.
38. Miller JD, Chu Y, Brooks RM, Richenbacher WE, Pena-Silva R, et al. (2008) Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. Journal of the American College of Cardiology 52: 843-850.
39. de Kreutzenberg SV, Ceolotto G, Papparella I, Bortoluzzi A, Semplicini A, et al. (2010) Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 59: 1006-1015.
40. Abdelmohsen K, Pullmann R Jr, Lal A, Kim HH, Galban S, et al. (2007) Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25: 543-557.
41. Lorenzi I, von Eckardstein A, Cavelier C, Radosavljevic S, Rohrer L, (2008) Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI. Journal of Molecular Medicine 86: 171-183.
42. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, et al. (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS medicine 1: e45.
43. Kunnari AM, Savolainen ER, Ukkola OH, Kesaniemi YA, Jokela MA, (2009) The expression of human resistin in different leucocyte lineages is modulated by LPS and TNFalpha. Regulatory peptides 157: 57-63.
44. Singh AK, Battu A, Mohareer K, Hasnain SE, Ehtesham NZ, (2010) Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma). PLoS ONE 5: e9912.
45. Schwartz DR, Lazar MA, (2011) Human resistin: found in translation from mouse to man. Trends in endocrinology and metabolism: TEM 22: 259-265.
46. Chawla A, (2010) Control of macrophage activation and function by PPARs. Circ Res 106: 1559-1569.
47. Li X, Zhang S, Blander G, Tse JG, Krieger M, et al. (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 28: 91-106.
48. Takemura A, Iijima K, Ota H, Son BK, Ito Y, et al. (2011) Sirtuin 1 Retards Hyperphosphatemia-Induced Calcification of Vascular Smooth Muscle Cells. Arteriosclerosis, thrombosis, and vascular biology 31: 2054-2062.